How Breast Cancer Cells Survive in Bone Marrow After Remission Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

“While lanreotide and everolimus have each previously demonstrated the ability to extend progression-free survival in patients with gastroenteropancreatic neuroendocrine tumors, combination treatment ...

Bone cancer is characterized by uncontrolled growth of cells of the bone. Primary bone cancer (that arises directly in the bone), is relatively rare. Different types of bone tissue give rise to ...

Joint pain. Bone swelling. These are symptoms that about 1,000 people in the United States begin to feel each year shortly before being diagnosed with osteosarcoma, a type of cancer that starts in ...

However, the combination of lanreotide and everolimus has not previously been studied, ASCO expert Laura Vater, MD, MPH, with Indiana University Simon Cancer Center, Indianapolis, said in a statement.

Feb. 3, 2025 — A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease ... Routine Brain ...

Get Instant Summarized Text (Gist) Genomic analysis has identified a novel mutation mechanism, loss-translocation-amplification (LTA) chromothripsis, in approximately 50% of high-grade ...

Credit: Karen Arnott/EMBL-EBI A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging cancer. A large-scale analysis of patient ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...

Somatostatin analogs such as octreotide and lanreotide are the cornerstone of treatment for functional neuroendocrine tumors. 1,14 These agents control symptoms by inhibiting hormone secretion and ...